Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Creabilis, a clinical stage European biotechnology company has named Eliot Forster as the new CEO of the company.
Subscribe to our email newsletter
Most recently, Forster was the CEO of Solace Pharmaceuticals.
Before joining Solace Pharma, Forster was the head of EU Development and of Development Operations in the EU & Asia at Pfizer.
Creabilis chairman George Horner III said that they are delighted that Eliot has joined Creabilis. His proven drug development experience will be extremely valuable as we work to further advance of exciting pipeline of clinical drug candidates.
“Eliot’s appointment is another important step in Creabilis bringing highly innovative treatments for skin diseases to market,” Horner said.